Enlivex Therapeutics (Israel) Analysis
| ENLV Stock | ILA 397.00 1.50 0.38% |
Enlivex Therapeutics is overvalued with Real Value of 365.11 and Hype Value of 397.0. The main objective of Enlivex Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Enlivex Therapeutics is worth, separate from its market price. There are two main types of Enlivex Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Enlivex Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Enlivex Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Enlivex Therapeutics stock is traded in Israel on Tel Aviv Stock Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Sun except for officially observed holidays in Israel. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Enlivex Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Enlivex |
Enlivex Stock Analysis Notes
About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.23. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enlivex Therapeutics recorded a loss per share of 1.07. The entity had not issued any dividends in recent years. Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel. ENLIVEX THERAPEUTI operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 50 people. To learn more about Enlivex Therapeutics call Dror Mevorach at (972) 2 6208070 or check out www.enlivex.com.Enlivex Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Enlivex Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Enlivex Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Enlivex Therapeutics generated a negative expected return over the last 90 days | |
| Enlivex Therapeutics has high historical volatility and very poor performance | |
| Net Loss for the year was (14.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Enlivex Therapeutics has accumulated about 90.6 M in cash with (17.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.95. | |
| Roughly 12.0% of the company shares are held by company insiders |
Enlivex Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 273.23 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Enlivex Therapeutics's market, we take the total number of its shares issued and multiply it by Enlivex Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 31st of January, Enlivex Therapeutics shows the Standard Deviation of 3.69, mean deviation of 2.84, and Variance of 13.6. Enlivex Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Enlivex Therapeutics Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Enlivex Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Enlivex Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Enlivex Therapeutics Outstanding Bonds
Enlivex Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Enlivex Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Enlivex bonds can be classified according to their maturity, which is the date when Enlivex Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Enlivex Therapeutics Predictive Daily Indicators
Enlivex Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Enlivex Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0428 | |||
| Daily Balance Of Power | (0.08) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 404.45 | |||
| Day Typical Price | 401.97 | |||
| Market Facilitation Index | 17.7 | |||
| Price Action Indicator | (8.20) | |||
| Period Momentum Indicator | (1.50) |
Enlivex Therapeutics Forecast Models
Enlivex Therapeutics' time-series forecasting models are one of many Enlivex Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Enlivex Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Enlivex Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Enlivex Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Enlivex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Enlivex Therapeutics. By using and applying Enlivex Stock analysis, traders can create a robust methodology for identifying Enlivex entry and exit points for their positions.
Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel. ENLIVEX THERAPEUTI operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 50 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Enlivex Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Complementary Tools for Enlivex Stock analysis
When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |